1. Asano, M., Yukita, A., Matsumoto, T., Kondo, S. & Suzuki, H. (1995). Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121 . Cancer Res 55: 5296–5301.
2. Bochner, B. H., Cote, R. J., Weidner, N., Groshen, S., Chen, S. C., Skinner, D. G. & Nichols, P. W. (1995). Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis. J Natl Cancer Inst 87: 1603–1612.
3. Brizel, D. B., Scully, S. P., Harrelson, J. M., Layfield, L. J., Bean, J. M., Prosnitz, L. R. & Dewhirst, M. W. (1996). Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56: 941–943.
4. Brown, J. M. & Giaccia, A. J. (1994). Tumour hypoxia: the picture has changed in the 1990s. Int J Radiat Biol 65: 95–102.
5. Claffey, K. P., Brown, L. F., del Aguila, L. F., Tognazzi, K., Yeo, K-T, Manseau, E. J. & Dvorak, H. F. (1996). Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res 56: 172–181.